Clinical Trial Update: A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of FIX prophylaxis for adult Hemophilia B and FVIII prophylaxis for adult Hemophilia A; the study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Factor IX Prophylaxis Replacement Therapy (Factor IX replacement therapy)
• Factor VIII Prophylaxis Replacement Therapy (Factor VIII replacement therapy)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B, Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2025-11-06